Esperion Secures Key Patent Settlement with Dr. Reddy’s, Protecting NEXLETOL and NEXLIZET Until 2040

Esperion announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laborato...

October 06, 2025 | Monday | News
Harrow to Acquire Melt Pharmaceuticals, Advancing Non-Opioid, Needle-Free Sedation Therapy MELT-300

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it has entered into an ag...

September 30, 2025 | Tuesday | News
Lupin to Acquire VISUfarma from GHO Capital, Expanding Ophthalmology Footprint in Europe

Global pharma major Lupin Limited (Lupin), announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisi...

September 29, 2025 | Monday | News
Pfizer Tucks Into $4.9 Billion Metsera Feast — Because Nothing Says Slimming Like Bulking Up

  Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valu...

September 23, 2025 | Tuesday | News
Thermo Fisher Finalises $4B Solventum Filtration Deal Expanding Bioprocessing Portfolio and Adjacent Markets

Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the w...

September 03, 2025 | Wednesday | News
Thermo Fisher Expands Strategic Partnership with Sanofi to Boost U.S. Manufacturing Capacity

Expanded Strategic Partnership Enables Additional U.S. Manufacturing Capacity to Serve Increased Demand for Pharma/Biotech Customers Thermo Fisher Scien...

September 03, 2025 | Wednesday | News
AutoMax’s Shareholders Approve Merger with SciSparc

SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to...

September 01, 2025 | Monday | News
MannKind to Acquire scPharmaceuticals in $360 Million Deal, Expanding Into Cardiorenal Medicine With FUROSCIX®

  Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic...

August 26, 2025 | Tuesday | News
Terumo Acquires OrganOx in $1.5 Billion Deal to Transform Global Organ Transplantation

- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine - Terumo Corporation announced ...

August 25, 2025 | Monday | News
Tivic Health Acquires Entolimod™ INDs to Advance ARS and Cancer Trials

INDs Transferred from Statera Biopharma Advance Entolimod for ARS Along Regulatory Pathway and Enable Pursuit of Clinical Trial Program in Neutropenia ...

August 21, 2025 | Thursday | News
Intas Strengthens Global Leadership in Pegfilgrastim with UDENYCA® Acquisition

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the worl...

August 08, 2025 | Friday | News
Sanofi Completes $470M Acquisition of Vigil Neuroscience to Strengthen Neurology Pipeline

Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. (“Vigil”). This acquisition strengthens Sanofi’s ea...

August 07, 2025 | Thursday | News
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million All-Cash Deal

SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on medicines for rare diseases and medical emergencies, and ...

August 06, 2025 | Wednesday | News
Yatiri Bio Acquires NGeneBioAI to Accelerate AI-Driven Plasma Proteomics and Precision Diagnostics

Yatiri Bio, Inc., a leader in proteomics-driven precision medicine, announced the successful acquisition of NGeneBioAI, Inc., a San Diego-based company s...

August 06, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close